Candel Therapeutics Shows Promise in Pancreatic Cancer Treatment
Friday, 5 April 2024, 12:56
Candel Therapeutics Stock Surge
Shares of Candel Therapeutics climbed early Friday after the company released new data on its experimental cancer treatment.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.